Abstract:Objective: Ginsenoside Rh1 (G-Rh1) has been confirmed to inhibit the growth of breast cancer and colon cancer, but its therapeutic effect on hepatocellular carcinoma (HCC) is unclear. This study investigates the therapeutic effect of G-Rh1 on HCC as well as the underlying mechanism. Methods: Bioinformatics methods were used to analyze glucocorticoid receptor (GR) expression and the tumor microenvironment in HCC tissues from HCC patients. The effect of G-Rh1 on HCC cells was investigated in vitro using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method. The therapeutic effect of G-Rh1 was investigated in vivo using subcutaneous transplantation models in C57BL/6J and nude mice. Additionally, the proportion of infiltrating immune cells in tumors was analyzed using flow cytometry, the GR and major histocompatibility complex class-I (MHC-I) expression of HCC cells after G-Rh1 treatment was analyzed using Western blotting, and G-Rh1-treated Hepa1-6 cells were cocultured with bone marrow-derived dendritic cells and B3Z T cells to further analyze the ability of G-Rh1 to induce dendritic cell (DC) maturation and CD8+ T cell activation. Results: GR expression was upregulated in HCC tissues, and high GR expression was associated with a worsened immune microenvironment. In vitro studies showed that G-Rh1 had no significant effect on the proliferation of HCC cells, while in vivo studies showed that G-Rh1 exerted antitumor effects in C57BL/6J mice but not in nude mice. Further research revealed that G-Rh1 ameliorated the immunosuppressive tumor microenvironment, thereby enhancing the antitumor effects of lenvatinib by increasing the infiltration of CD8+ T cells, mature DCs, and MHC-I-positive cells. MHC-I was upregulated by G-Rh1 via GR suppression. Moreover, overexpression of GR abolished the G-Rh1-mediated promotion of MHC-I expression in Huh7 cells, as well as the maturation of DCs and the activation of CD8+ T cells. Conclusion: G-Rh1 can regulate the immune microenvironment of HCC by targeting GR, thus increasing the antitumor effect of lenvatinib. Please cite this article as: Wang XH, Fu YL, Xu YN, Zhang PC, Zheng TX, Ling CQ, Feng YL. Ginsenoside Rh1 regulates the immune microenvironment of hepatocellular carcinoma via the glucocorticoid receptor. J Integr Med. 2024; Epub ahead of print.

Ginsenoside Rh2 and Its Octyl Ester Derivative Inhibited Invasion and Metastasis of Hepatocellular Carcinoma Via the C-Jun/cox2/pge2 Pathway.

Antitumor and Immunomodulatory Effects of Ginsenoside Rh2 and Its Octyl Ester Derivative in H22 Tumor-Bearing Mice

20(S)-Ginsenoside Rh2 inhibits hepatocellular carcinoma by suppressing angiogenesis and the GPC3-mediated Wnt/β‑catenin signaling pathway

Octyl Ester of Ginsenoside Rh2 Induces Apoptosis and G1 Cell Cycle Arrest in Human HepG2 Cells by Activating the Extrinsic Apoptotic Pathway and Modulating the Akt/p38 MAPK Signaling Pathway.

Esterification of ginsenoside Rh2 enhanced its cellular uptake and antitumor activity in human HepG2 cells.

20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription

The immunomodulatory effects of ginsenoside derivative Rh2-O on splenic lymphocytes in H22 tumor-bearing mice is partially mediated by TLR4

Effects of the Gensenoside on Invasion and Migration of Hepatic Carcinoma Bel-7402 Cells

Ginsenoside Rh2 Inhibits Hepatocellular Carcinoma Through Β-Catenin and Autophagy

Ginsenoside Rh2 suppresses colon cancer growth by targeting the miR-150-3p/SRCIN1/Wnt axis

Ginsenoside Rh2 Attenuates the Progression of Non-Small Cell Lung Cancer by Sponging Mir-28-5p/stk4 Axis and Inactivating Wnt/-catenin Signaling

Experimental Study on Gensenoside Rh2 Inhibiting the Invasion and Migration of Breast Cancer Cells

Knockdown of Cyclooxygenase-2 Leads to Growth Inhibition and Cell Cycle Arrest in Hepatocellular Carcinoma Cells.

Experimental Study of Rhein Inhibiting the Invasion and Migration of the HepG2 Cells by Extracellular Signal-Regulated Kinase Signaling Pathway

Ginsenoside Rh4 inhibits inflammation-related hepatocellular carcinoma progression by targeting HDAC4/IL-6/STAT3 signaling

Ginsenoside Rh2 impedes proliferation and migration and induces apoptosis by regulating NF‐κB, MAPK, and PI3K/Akt/mTOR signaling pathways in osteosarcoma cells

Ginsenoside Rg5 Inhibits Cancer Cell Migration by Inhibiting the Nuclear Factor-Κb and Erythropoietin-Producing Hepatocellular Receptor A2 Signaling Pathways.

Potential Involvement of the Cyclooxygenase-2 Pathway in Hepatocellular Carcinoma-Associated Angiogenesis

Ginsenoside Rh1 regulates the immune microenvironment of hepatocellular carcinoma via the glucocorticoid receptor

The Octyl Ester of Ginsenoside Rh2 Induces Lysosomal Membrane Permeabilization Via Bax Translocation

Structural Modification of Ginsenoside Rh-2 by Fatty Acid Esterification and Its Detoxification Property in Antitumor